
UK biotech firm Oxyrane has expanded to the US and made a number of senior appointments. The privately-owned Manchester-based company’s first …
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer

